Compound Profile: IGF DES 1-3 Pharmaqo
IGF DES 1-3 is a modified insulin-like growth factor peptide synthesised for in-vitro laboratory research applications. This truncated variant lacks the first three amino acids of the N-terminal region, resulting in altered receptor binding characteristics compared to full-length IGF-1. Pharmaqo’s research-grade formulation provides scientists with a standardised compound for investigating IGF receptor pathway modulation in cellular and molecular biology studies. Researchers at Stroid UK Shop utilise this peptide to examine growth factor signalling cascades and receptor-ligand interactions in controlled experimental environments.
Laboratory Applications
Scientific investigations with IGF DES 1-3 focus on examining insulin-like growth factor receptor binding dynamics and downstream signalling pathway activation. The modified structure demonstrates enhanced binding affinity to IGF-1 receptors in cell culture systems, making it valuable for research into growth factor biology and cellular proliferation mechanisms. Laboratory studies investigate this peptide’s role in muscle tissue research, examining how growth factor modifications affect cellular responses in myoblast cultures. Research teams studying IGF-1 peptides utilise this compound to analyse receptor selectivity and binding kinetics. Comparative studies with other peptides help elucidate structure-function relationships in growth factor research. Additionally, researchers examine this peptide alongside SARMs to understand different approaches to cellular growth pathway modulation.
Technical Specifications
| Peptide Name | IGF DES 1-3 |
|---|---|
| Manufacturer | Pharmaqo |
| CAS Number | Verify with supplier |
| Molecular Formula | Verify with supplier |
| Molecular Weight | Verify with supplier |
| Form | Lyophilised powder |
| Storage | -20°C (dry), 2-8°C (reconstituted) |
| Stability | Verify with supplier |
Research Compliance
IGF DES 1-3 is manufactured exclusively for laboratory research purposes and in-vitro experimental applications. This product is not intended for human consumption, therapeutic use, or any application outside controlled scientific research environments. Researchers must maintain appropriate laboratory protocols and safety measures when handling this research peptide. All experimental work should be conducted by qualified personnel in properly equipped research facilities with adequate ventilation and safety protocols.
